{"id":51501,"date":"2022-12-02T13:02:21","date_gmt":"2022-12-02T12:02:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/human-factors-usability-studies-following-iso-62366-and-the-new-fda-guidance-webinar-researchandmarkets-com\/"},"modified":"2022-12-02T13:02:21","modified_gmt":"2022-12-02T12:02:21","slug":"human-factors-usability-studies-following-iso-62366-and-the-new-fda-guidance-webinar-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/human-factors-usability-studies-following-iso-62366-and-the-new-fda-guidance-webinar-researchandmarkets-com\/","title":{"rendered":"Human Factors\/Usability Studies Following ISO 62366 and the New FDA Guidance – Webinar – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Human Factors\/Usability Studies following ISO 62366 and the new FDA Guidance”<\/a> webinar has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe FDA will only approve devices which are designed so that it is practically impossible for people to accidentally harm themselves even if they use the device improperly. The FDA has replaced the term “user error” with “use error”.\n<\/p>\n

\nThis means that use error is considered by the FDA to be a device nonconformity because human factors should be considered in the design process. The burden is on the device designer to create an “idiot proof” product.\n<\/p>\n

\nWho Should Attend:<\/strong>\n<\/p>\n